Clinical Cancer Research Meeting Calendar Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Handerson, T.
Right arrow Articles by Pawelek, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Handerson, T.
Right arrow Articles by Pawelek, J.
Clinical Cancer Research Vol. 11, 2969-2973, April 15, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

ß1,6-Branched Oligosaccharides Are Increased in Lymph Node Metastases and Predict Poor Outcome in Breast Carcinoma

Tamara Handerson1, Robert Camp2,4, Malini Harigopal2,4, David Rimm2,4 and John Pawelek3,4

Authors' Affiliations: 1 Department of Pathology, University of Massachusetts School of Medicine, Worchester, Massachusetts; Departments of 2 Pathology and 3 Dermatology, and 4 Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut

Requests for reprints: John M. Pawelek, Department of Dermatology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520-8059. Phone: 203-785-4411; Fax: 203-785-7637; E-mail: john.pawelek{at}yale.edu.

Purpose: This study was designed to provide a comprehensive assessment on the role of ß1,6-branched oligosaccharides in the metastasis and outcome of breast carcinoma. Generation of these structures on N-glycans is initiated by ß1,6-N-acetylglucosaminyltransferase V and used by both myeloid cells and cancer cells in systemic migration.

Experimental Design: Tissue microarrays of >700 tumors (>400 patients; 30-year follow-up data) were stained through lectin histochemistry with leukocytic phytohemagglutinin (LPHA), a selective marker for ß1,6-branched oligosaccharides. Node-negative and node-positive primary tumors and patient-matched lymph node metastases were scored by blinded observers.

Results: Metastases stained at significantly greater intensities than did the patient-matched primary tumors (P < 0.0001), demonstrating for the first time that the abundance of ß1,6-branched oligosaccharides was directly associated with breast carcinoma nodal metastasis. Multivariate analyses revealed that ß1,6-branched oligosaccharides in primary tumors were a predictor of poor outcome, most notably in node-negative tumors, where an LPHA staining score of 3+ gave a risk factor of 3.3, independent of tumor size, nuclear grade, or patient age (P = 0.007).

Conclusions: The data firmly establish a role for ß1,6-N-acetylglucosaminyltransferase V activity and ß1,6-branched oligosaccharides in breast carcinoma metastasis, and reemphasize the involvement, although poorly understood, of aberrant glycosylation in tumor progression.

Key Words: N-glycosylation • GnT-V • tumor progression • Kaplan-Meier analyses • vesicular phenotype




This article has been cited by other articles:


Home page
GlycobiologyHome page
H.-B. Guo, H. Johnson, M. Randolph, I. Lee, and M. Pierce
Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis
Glycobiology, May 1, 2009; 19(5): 547 - 559.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
X. Wei and L. Li
Comparative glycoproteomics: approaches and applications
Brief Funct Genomic Proteomic, March 1, 2009; 8(2): 104 - 113.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Z. Kyselova, Y. Mechref, P. Kang, J. A. Goetz, L. E. Dobrolecki, G. W. Sledge, L. Schnaper, R. J. Hickey, L. H. Malkas, and M. V. Novotny
Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles
Clin. Chem., July 1, 2008; 54(7): 1166 - 1175.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Li, Y. Li, X. Wu, Q. Li, J. Yu, J. Gen, and X.-L. Zhang
Knockdown of Mgat5 Inhibits Breast Cancer Cell Growth with Activation of CD4+ T Cells and Macrophages
J. Immunol., March 1, 2008; 180(5): 3158 - 3165.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
F. H.M. de Melo, D. Butera, R. S. Medeiros, L. N. d. S. Andrade, S. Nonogaki, F. A. Soares, R. A. Alvarez, A. M. Moura da Silva, and R. Chammas
Biological Applications of a Chimeric Probe for the Assessment of Galectin-3 Ligands
J. Histochem. Cytochem., October 1, 2007; 55(10): 1015 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-B. Guo, M. Randolph, and M. Pierce
Inhibition of a Specific N-Glycosylation Activity Results in Attenuation of Breast Carcinoma Cell Invasiveness-related Phenotypes: INHIBITION OF EPIDERMAL GROWTH FACTOR-INDUCED DEPHOSPHORYLATION OF FOCAL ADHESION KINASE
J. Biol. Chem., July 27, 2007; 282(30): 22150 - 22162.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. R. Drake, E. E. Schwegler, G. Malik, J. Diaz, T. Block, A. Mehta, and O. J. Semmes
Lectin Capture Strategies Combined with Mass Spectrometry for the Discovery of Serum Glycoprotein Biomarkers
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1957 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. F. Siddiqui, J. Pawelek, T. Handerson, C.-Y. Lin, R. B. Dickson, D. L. Rimm, and R. L. Camp
Coexpression of {beta}1,6-N-Acetylglucosaminyltransferase V Glycoprotein Substrates Defines Aggressive Breast Cancers with Poor Outcome
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2517 - 2523.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.